Type-I interferons induce lung protease responses following respiratory syncytial virus infection via RIG-I-like receptors

The role of proteases in viral infection of the lung is poorly understood. Thus, we examined matrix metalloproteinases (MMPs) and cathepsin proteases in respiratory syncytial virus (RSV)-infected mouse lungs. RSV-induced gene expression for MMPs -2, -3, -7, -8, -9, -10, -12, -13, -14, -16, -17, -19, -20, -25, -27, and -28 and cathepsins B, C, E, G, H, K, L1, S, W, and Z in the airways of Friend leukemia virus B sensitive strain mice. Increased proteases were present in the bronchoalveolar lavage fluid (BALF) and lung tissue during infection. Mitochondrial antiviral-signaling protein (MAVS) and TIR-domain-containing adapter-inducing interferon-β-deficient mice were exposed to RSV. Mavs-deficient mice had significantly lower expression of airway MMP-2, -3, -7, -8, -9, -10, -12, -13, and -28 and cathepsins C, G, K, S, W, and Z. In lung epithelial cells, retinoic acid-inducible gene-1 (RIG-I) was identified as the major RIG-I-like receptor required for RSV-induced protease expression via MAVS. Overexpression of RIG-I or treatment with interferon-β in these cells induced MMP and cathepsin gene and protein expression. The significance of RIG-1 protease induction was demonstrated by the fact that inhibiting proteases with batimastat, E64 or ribavirin prevented airway hyperresponsiveness and enhanced viral clearance in RSV-infected mice.

Accelerated partial breast irradiation (APBI): Are breath-hold and volumetric radiation therapy techniques useful?

<b>Background: b>In a selective group of patients accelerated partial breast irradiation (APBI) might be applied after conservative breast surgery to reduce the amount of irradiated healthy tissue. The role of volumetric modulated arc therapy (VMAT) and voluntary moderately deep inspiration breath-hold (vmDIBH) techniques in further reducing irradiated healthy – especially heart – tissue is investigated.

<b>Material and methods:b> For 37 partial breast planning target volumes (PTVs), three-dimensional conformal radiotherapy (3D-CRT) (3 – 5 coplanar or non-coplanar 6 and/or 10 MV beams) and VMAT (two partial 6 MV arcs) plans were made on CTs acquired in free-breathing (FB) and/or in vmDIBH. Dose-volume parameters for the PTV, heart, lungs, and breasts were compared. 

<b>Results: b>Better dose conformity was achieved with VMAT compared to 3D-CRT (conformity index 1.24 0.09 vs. 1.49 0.20). Non-PTV ipsilateral breast receiving 50% of the prescribed dose was on average reduced by 28% in VMAT plans compared to 3D-CRT plans. Mean heart dose (MHD) reduced from 2.0 (0.1 – 5.1) Gy in 3D-CRT(FB) to 0.6 (0.1 – 1.6) Gy in VMAT(vmDIBH). VMAT is benefi cial for MHD reduction if MHD with 3D-CRT exceeds 0.5Gy. Cardiac dose reduction as a result of VMAT increases with increasing initial MHD, and adding vmDIBH reduces the cardiac dose further. Mean dose to the ipsilateral lung decreased from 3.7 (0.7 – 8.7) to 1.8 (0.5 – 4.0) Gy with VMAT(vmDIBH) compared to 3D-CRT(FB). VMAT resulted in a slight increase in the contralateral breast dose (DMean ) always remaining 1.9 Gy). 

<b>Conclusions:b> For APBI patients, VMAT improves PTV dose conformity and delivers lower doses to the ipsilateral breast and lung compared to 3D-CRT. This goes at the cost of a slight but acceptable increase of the contralateral breast dose. VMAT reduces cardiac dose if MHD exceeds 0.5 Gy for 3D-CRT. Adding vmDIBH results in a further reduction of heart and ipsilateral lung dose. 

Metastatic melanoma:A regional review and future directions

Aims and background. The incidence of malignant melanoma has risen steadily over recent decades. NCI data from 2005-2007 have suggested that 1.93% of individuals born today in the US will develop melanoma at some stage. Approximately 15% of patients with MM either present with metastatic disease or develop metastases during the course of their illness. Unfortunately, metastatic MM remains a challenge with limited treatment options, and median overall survival is 6-9 months. Methods. We reviewed our data for the treatment of metastatic MM over a period of four years. Data from all patients with metastatic MM treated with systemic therapy without clinical trials from 2006 to 2009 were reviewed. Response rate was determined as per RECIST criteria. Results. Sixty four patients were treated with one or more lines of cytotoxic therapy. Median age was 62 years (range, 23-82) with 53% males. Primary site of the disease was the skin in 75%, mucosal in 12.5%, ocular in 9.4% and nodal with an occult primary in 3.1%. Visceral metastases were present in 75% of patients at the start of treatment, including pulmonary (39.6%) and hepatic (34.4%). All patients were screened for brain metastases, which were present in 26.5% of patients. ECOG performance status was 0 in 7.8%, 1 in 68.7%, 2 in 9.4% and undocumented in the remaining 14%. Patients without brain metastases received single agent DTIC as first line; those with brain metastases received temozolomide. Response rate was 7% for DTIC and 28% for temozolomide, with median progression-free survival of 2.4 and 3.2 months, respectively. Seven patients who received DTIC are alive on follow-up, 2 have ongoing stable disease post-DTIC at 41 months and 18 months. Second line therapy with vinblastine was given to 21 patients (32%), with a response rate of 9.5% and median progression-free survival of 3.4 months. Median overall survival from initiation of therapy was 7.7 months for DTIC and 3.6 months for patients with brain metastases receiving temozolomide. A performance status of 2 was associated with shorter median overall survival (2.0 months). Conclusions. Our results are comparable to published data. Malignant melanoma is a disease with rising incidence and limited treatment options. These patients are best treated in the context of clinical trials as new targeted therapies are promising as future strategies. © Il Pensiero Scientifico Editore.

Acid-labile protein-adducted heterocyclic aromatic amines in human blood are not viable biomarkers of dietary exposure: A systematic study.

Heterocyclic aromatic amines (HCA) are carcinogenic mutagens formed during cooking of protein-rich foods. HCA residues adducted to blood proteins have been postulated as biomarkers of HCA exposure. However, the viability of quantifying HCAs following hydrolytic release from adducts in vivo and correlation with dietary intake are unproven. To definitively assess the potential of labile HCA-protein adducts as biomarkers, a highly sensitive UPLC-MS/MS method was validated for four major HCAs: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline (4,8-DiMeIQx) and 2-amino-3,7,8-trimethylimidazo[4,5-f]quinoxaline (7,8-DiMeIQx). Limits of detection were 1e5 pg/ml plasma and recoveries 91e115%. Efficacy of hydrolysis was demonstrated by HCA-protein adducts synthesised in vitro. Plasma and 7-day food diaries were collected from 122 fasting adults consuming their habitual diets. Estimated HCA intakes ranged from 0 to 2.5 mg/day. An extensive range of hydrolysis conditions was examined for release of adducted HCAs in plasma. HCA was detected in only one sample (PhIP, 9.7 pg/ml), demonstrating conclusively for the first time that acid-labile HCA adducts do not reflect dietary HCA intake and are present at such low concentrations that they are not feasible biomarkers of exposure. Identification of biomarkers remains important. The search should concentrate on stabilised HCA peptide markers and use of untargeted proteomic and metabolomic approaches.

House Diaries

Short film/video art (mini DV 2’.10’’) featuring urban landscapes and domestic housing previously displayed as part of the 2nd Athens Video Art Festival 2006.7, 8, 9 April 2006 Aggelon Vima.

Étude de profils psychomoteurs d'enfants à hauts potentiels intellectuels en difficulté d'apprentissage à l'école primaire française

Cette recherche professionnelle porte sur les profils psychomoteurs d'un échantillon de 83 enfants français, garçons et filles de 7, 8 et 9 ans à hauts potentiels intellectuels rencontrant des difficultés pour apprendre à l'école primaire. Elle est mise en oeuvre au moyen d'une méthodologie mixte. Née en France, la psychomotricité est un corpus paramédical qui propose une approche éducative et de remédiation des difficultés d'apprentissage, à partir d'une conception du développement psychomoteur qui considère que les interrelations entre les fonctionnements corporels, les éprouvés émotionnels et les cognitions sont primordiales et qu'elles se réalisent et sont accessibles via l'expérience corporelle globalisante. Ce construit, et les outils d'évaluation qui en découlent, c'est-à-dire le bilan psychomoteur, sont ici mobilisés pour décrire les profils adaptatifs d'enfants à hauts potentiels intellectuels en souffrance pour apprendre. Si les principaux travaux consacrés à ces enfants hors-normes et à leurs développements atypiques évoquent leur sensibilité et fragilité, ils sont trop souvent restreints aux seuls aspects du quotient intellectuel. Les apports de la psychomotricité peuvent donc les compléter. À partir de la description du dialogue tonicoémotionnel, qui inscrit le sujet dans la continuité biologiquepsychologique, l'expérience du corps, sous le double effet de la maturation neuromotrice et du bain environnemental, évolue vers la différenciation des fonctions psychomotrices qui permet la maîtrise gestuelle, la représentation du corps, de l'espace et du temps. Ces descriptions sont cohérentes avec d'autres conceptions multi-référencées qui reconnaissent aux émotions et à leur devenir un rôle important dans le développement, comme la théorie de l'attachement. Elles conduisent au repérage de troubles psychomoteurs. Ceux-ci peuvent friner l'accès aux apprentissages scolaires notamment l'écriture. Ce sont des perturbations de l'équilibre psychocorporel. Par définition et spécifiquement, ils ne répondent pas à une atteinte neurologique et expriment une souffrance psychique. L'analyse centrée sur les variables fournit une vision générale des données collectées. Les corrélations entre les 30 rubriques sont étudiées en les classant par sphères correspondant aux fonctions psychomotrices - motricité - rythme - espace - intégration corporelle - graphomotricité; puis par processus - tonicoémotionnel - sensori-perceptivo-moteur - cognitif - apprentissage explicité. Cette taxonomie éclaire les corrélations et donc les niveaux d'organisation. Ce premier traitement statistique débouche sur a) l'intérêt de la démarche globale en psychomotricité puisque toutes les rubriques étudiées se sont avérées troublées, b) l'apport de la prise en considération des dimensions tonicoémotionnelles, c) l'importance de l'articulation sensori-perceptivo-motrice et d) une confirmation des liens entre les compétences psychomotrices et l'écriture. La seconde étape est une classification hiérarchique ascendante puis une analyse factorielle des grappes. Elle dégage des résultats concernant des différences entre les organisations internes de ces enfants sous-réalisateurs, à partir des poids respectifs des facteurs 1) de la dyspraxie et de la dysgraphie, 2) de l'hyperactivité et de l'anxiété avec impulsivité et difficultés graphiques, 3) des troubles de la motricité large et fine et de l'expression émotionnelle, 4) des troubles spatiaux, 5) des troubles visuopraxiques et de l'intégration corporelle floue, 6) des troubles diffus et légers et 7) des troubles du rythme. Ainsi les cinq grappes sont décrites de manière dynamique comme caractérisées par 1) de bonnes compétences scripturales, des difficultés légères mais aussi des perturbations du tonus musculaire, 2) des tendances dysgraphiques pour des enfants maladroits et inquiets mais aussi avec des compétences préservées, qui se différencient 3) d'enfants franchement dysgraphiques avec des difficultés à se situer et manier les informations relatives à l'espace et au rythme, 4) d'enfants également dysgraphiques mais aussi hyperactifs, anxieux et manquant de référence spatio-temporelle, et 5) de sujets qui dysgraphiques, dyspraxiques, émotifs ont des tendances hyperactives et des incertitudes visuopraxiques. Ainsi à partir de la référence holistique-interactionniste, ces résultats confirment l'intérêt des approches globales et multi-référencées pour explorer les profils des enfants dont le développement n'est pas harmonieux et qui se trouvent confrontés à des difficultés pour apprendre dans le cadre scolaire.

Effect of temperature on embryonic development, larval viability and biomarkers in the first stages of life of Octopus Vulgaris (Cuvier, 1797)

Dissertação de Mestrado, Aquacultura e Pescas, Faculdade de Ciências e Tecnologia, Universidade do Algarve, 2015

Extracorporeal membrane oxygenation support after heart explantation: a proposal on how to deal with hyperacute rejection of heart transplant

Purpose: In extreme situations, such as hyperacute rejection of heart transplant or major bleeding per-operating complications, an urgent heart explantation might be the only means of survival. The aim of this experimental study was to improve the surgical technique and the hemodynamics of an Extracorporeal Membrane Oxygenation (ECMO) support through a peripheral vascular access in an acardia model. Methods: An ECMO support was established in 7 bovine experiments (59±6.1 kg) by the transjugular insertion to the caval axis of a self-expanded cannula, with return through a carotid artery. After baseline measurements of pump flow and arterial and central venous pressure, ventricular fibrillation was induced (B), the great arteries were clamped, the heart was excised and right and left atria remnants, containing the pulmonary veins, were sutured together leaving an atrial septal defect (ASD) over the cannula in the caval axis. Measurements were taken with the pulmonary artery (PA) clamped (C) and anastomosed with the caval axis (D). Regular arterial and central venous blood gases tests were performed. The ANOVA test for repeated measures was used to test the null hypothesis and a Bonferroni t method for assessing the significance in the between groups pairwise comparison of mean pump flow. Results: Initial pump flow (A) was 4.3±0.6 L/min dropping to 2.8±0.7 L/min (P B-A= 0.003) 10 minutes after induction of ventricular fibrillation (B). After cardiectomy, with the pulmonary artery clamped (C) it augmented not significantly to 3.5±0.8 L/min (P C-B= 0.33, P C-A= 0.029). Finally, PA anastomosis to the caval axis was followed by an almost to baseline pump flow augmentation (4.1±0.7 L/min, P D-B= 0.009, P D-C= 0.006, P D-A= 0.597), permitting a full ECMO support in acardia by a peripheral vascular access. Conclusions: ECMO support in acardia is feasible, providing new opportunities in situations where heart must urgently be explanted, as in hyperacute rejection of heart transplant. Adequate drainage of pulmonary circulation is pivotal in order to avoid pulmonary congestion and loss of volume from the normal right to left shunt of bronchial vessels. Furthermore, the PA anastomosis to the caval axis not only improves pump flow but it also permits an ECMO support by a peripheral vascular access and the closure of the chest.

Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts.

The photosensitizing properties of m-tetrahydroxyphenylchlorin (mTHPC) and polyethylene glycol-derivatized mTHPC (pegylated mTHPC) were compared in nude mice bearing human malignant mesothelioma, squamous cell carcinoma and adenocarcinoma xenografts. Laser light (20 J/cm2) at 652 nm was delivered to the tumour (surface irradiance) and to an equal-sized area of the hind leg of the animals after i.p. administration of 0.1 mg/kg body weight mTHPC and an equimolar dose of pegylated mTHPC, respectively. The extent of tumour necrosis and normal tissue injury was assessed by histology. Both mTHPC and pegylated mTHPC catalyse photosensitized necrosis in mesothelioma xenografts at drug-light intervals of 1-4 days. The onset of action of pegylated mTHPC seemed slower but significantly exceeds that of mTHPC by days 3 and 4 with the greatest difference being noted at day 4. Pegylated mTHPC also induced significantly larger photonecrosis than mTHPC in squamous cell xenografts but not in adenocarcinoma at day 4, where mTHPC showed greatest activity. The degree of necrosis induced by pegylated mTHPC was the same for all three xenografts. mTHPC led to necrosis of skin and underlying muscle at a drug-light interval of 1 day but minor histological changes only at drug-light intervals from 2-4 days. In contrast, pegylated mTHPC did not result in histologically detectable changes in normal tissues under the same treatment conditions at any drug-light interval assessed. In this study, pegylated mTHPC had advantages as a photosensitizer compared to mTHPC. Tissue concentrations of mTHPC and pegylated mTHPC were measured by high-performance liquid chromatography in non-irradiated animals 4 days after administration. There was no significant difference in tumour uptake between the two sensitizers in mesothelioma, adenocarcinoma and squamous cell carcinoma xenografts. Tissue concentration measurements were of limited use for predicting photosensitization in this model.

Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00).

BACKGROUND: The aim of this study was to evaluate the efficacy and tolerability of fulvestrant, an estrogen receptor antagonist, in postmenopausal women with hormone-responsive tumors progressing after aromatase inhibitor (AI) treatment. PATIENTS AND METHODS: This is a phase II, open, multicenter, noncomparative study. Two patient groups were prospectively considered: group A (n=70) with AI-responsive disease and group B (n=20) with AI-resistant disease. Fulvestrant 250 mg was administered as intramuscular injection every 28 (+/-3) days. RESULTS: All patients were pretreated with AI and 84% also with tamoxifen or toremifene; 67% had bone metastases and 45% liver metastases. Fulvestrant administration was well tolerated and yielded a clinical benefit (CB; defined as objective response or stable disease [SD] for >or=24 weeks) in 28% (90% confidence interval [CI] 19% to 39%) of patients in group A and 37% (90% CI 19% to 58%) of patients in group B. Median time to progression (TTP) was 3.6 (95% CI 3.0 to 4.8) months in group A and 3.4 (95% CI 2.5 to 6.7) months in group B. CONCLUSIONS: Overall, 30% of patients who had progressed following prior AI treatment gained CB with fulvestrant, thereby delaying indication to start chemotherapy. Prior response to an AI did not appear to be predictive for benefit with fulvestrant.

The clinical application of converting enzyme inhibitors.

Chronic blockade of the renin angiotensin system became possible when orally active inhibitors of angiotensin converting enzyme, the enzyme which catalyzes the transformation of angiotensin I into angiotensin II, were synthetized. Two compounds, captopril and enalapril, have been investigated in clinical studies. The decrease of the pressor response to exogenous angiotensin I and of the circulating levels of angiotensin II following administration of these inhibitors has been demonstrated to be directly related to the degree of suppression of plasma angiotensin converting enzyme activity. These inhibitors have been shown to normalize blood pressure alone in some hypertensive patients whereas in many others, satisfactory blood pressure control can be achieved only after the addition of a diuretic. Captopril and enalapril also markedly improve cardiac function of patients with chronic congestive heart failure. Chronic blockade of the renin angiotensin system has therefore provided an interesting new approach to the treatment of clinical hypertension and heart failure.

Breviarium Strigoniense.

Cf. notice du ms. par Leroquais, Bréviaires, III, 182-185 n° 591 et pl. XCIX; P. Radó, Libri liturgici manuscripti bibliothecarum Hungariae et limitropharum regionum, Budapest, 1973. Un bréviaire d'Esztergom a été imprimé en 1524 à Venise. F. 2-8v Calendrier à l'usage d'Esztergom, avec un grand nombre de saints d'origines diverses (2-7v); cf. Leroquais, op. cit., 182. À noter les saints non mentionnés dans les Acta sanctorum, ou du moins pas pour la date correspondante; ne sont pas relevés les saints hongrois considérés comme classiques par Radó, op. cit., passim : 4 févr., «Victoris m.»; 8 févr., «Juliani m.»; 13 févr., «Adalberti m.», signalé une fois dans Radó, op. cit., 96 d'après ms. Budapest, B. N. Hung., c. l. m. ae. 395; 15févr., «Faustiani m.»; 21 févr., «Septuaginta mm.», non signalé sous cette forme pour cette date dans Radó, op. cit.; 15 mars, «Hilarii conf. et pont.», non signalé sous cette forme pour cette date dans Radó, op. cit.; 17 mars, «Bernardi conf.»; 26mars, «Eustachii abb.», signalé une fois dans Radó, op. cit., 96 d'après ms. Budapest, B.N. Hung., c. l. m. ae. 395; 28 mars, «Gastuli m.», non signalé dans Radó, op. cit.; 3 juill., «Bonifacii ep.», non signalé dans Radó, op. cit.; 5 juill., «Dominici m.»; 4 août, «Gaudentii ep. et conf.», signalé une fois dans Radó, op. cit., 329 d'après ms. Budapest, B. N. Hung., c. l. m. ae. 408; 8 août, «Adventus sanguinis D. N. J. C.»; 31 août, «Pauli ep. et m.», non signalé dans Radó, op. cit.; 12 oct., «Quatuor milium mm.», non signalé dans Radó, op. cit., à rapprocher de quatuor mille octingenti septuaginta mm., cf. Radó, op. cit., 167 d'après ms. Esztergom, B. metropolitana Strigoniensis I. 20; 14 oct., «Cerbonii conf.»; 27 oct., «Vedasti m.»; 15 nov., «Martini conf.», non signalé pour cette date dans Radó, op. cit; 20 nov., «Aniani ep. [Aurelianensis] et conf.». Pour plusieurs saints du calendrier on ne trouve pas d'office dans le sanctoral, et vice versa. — «Sequitur tabula impositionis historiarum...» (8-8v). F. 11-76 Psautier férial (11-72). — Office des défunts à l'usage d'Esztergom (72v-76); cf. K. Ottosen, The responsories and versicles of the latin office of the dead, Aarhus 1993, 127 (description des ff.74v-75v = «BN8879B») et 180 (description des ff.72v-74v = «BN8879A»). F. 77-528v Temporal : «Incipit breviarium secundum chorum alme ecclesie Strigoniensis. Dominica prima in adventu Domini...» (77-282v). Sanctoral : «Incipit secunda pars breviarii scilicet de festivitatibus. De s. Silvestro...» (286-486). À noter : office de l'Immaculée Conception composé par Léonard Nogarolo (480v). Commun des saints : «Incipit commune de sanctis et primo in vigilia unius apostoli...» (486v-513v). — «Sequitur de b. Virgine sabbatis diebus per estatem. Ad vesperas...» (513v-516v). «In quotidianis horis b. Virginis...» (516v-525). — «Sequuntur preces in quadragesima...» (525-526v). — «Sequuntur suffragia sabbatis diebus per estatem...» (526v-528), dont suffrages des ss. [Stephani regis Hungariae; Emerici ducis] (527), [Ladislai regis Hungariae; Adalberti ep. Pragensis et m.] (527v). — «Absolutio excommunicati...» (528-528v). 106 hymnes mentionnées dans la table des incipit, dont une non répertoriée dans Chevalier, Repert. hymn. ni dans les A. H., pour les confesseurs : «Christe lucis splendor vere fabrice mundi semper nobis parcens miserere confessorum precibus//...» (506v); cf. P. Radó, Répertoire hymnologique des mss. liturgiques dans les bibliothèques publiques de Hongrie, Budapest 1945, n° 111, relevée une fois dans le ms. Budapest, Bibl. nat. Hung. c. l. m. ae. 132, ms. décrit par Radó, Libri liturgici..., op. cit., 395-400.

Breviarium Strigoniense.

Cf. notice du ms. par Leroquais, Bréviaires, III, 182-185 n° 591 et pl. XCIX; P. Radó, Libri liturgici manuscripti bibliothecarum Hungariae et limitropharum regionum, Budapest, 1973. Un bréviaire d'Esztergom a été imprimé en 1524 à Venise. F. 2-8v Calendrier à l'usage d'Esztergom, avec un grand nombre de saints d'origines diverses (2-7v); cf. Leroquais, op. cit., 182. À noter les saints non mentionnés dans les Acta sanctorum, ou du moins pas pour la date correspondante; ne sont pas relevés les saints hongrois considérés comme classiques par Radó, op. cit., passim : 4 févr., «Victoris m.»; 8 févr., «Juliani m.»; 13 févr., «Adalberti m.», signalé une fois dans Radó, op. cit., 96 d'après ms. Budapest, B. N. Hung., c. l. m. ae. 395; 15févr., «Faustiani m.»; 21 févr., «Septuaginta mm.», non signalé sous cette forme pour cette date dans Radó, op. cit.; 15 mars, «Hilarii conf. et pont.», non signalé sous cette forme pour cette date dans Radó, op. cit.; 17 mars, «Bernardi conf.»; 26mars, «Eustachii abb.», signalé une fois dans Radó, op. cit., 96 d'après ms. Budapest, B.N. Hung., c. l. m. ae. 395; 28 mars, «Gastuli m.», non signalé dans Radó, op. cit.; 3 juill., «Bonifacii ep.», non signalé dans Radó, op. cit.; 5 juill., «Dominici m.»; 4 août, «Gaudentii ep. et conf.», signalé une fois dans Radó, op. cit., 329 d'après ms. Budapest, B. N. Hung., c. l. m. ae. 408; 8 août, «Adventus sanguinis D. N. J. C.»; 31 août, «Pauli ep. et m.», non signalé dans Radó, op. cit.; 12 oct., «Quatuor milium mm.», non signalé dans Radó, op. cit., à rapprocher de quatuor mille octingenti septuaginta mm., cf. Radó, op. cit., 167 d'après ms. Esztergom, B. metropolitana Strigoniensis I. 20; 14 oct., «Cerbonii conf.»; 27 oct., «Vedasti m.»; 15 nov., «Martini conf.», non signalé pour cette date dans Radó, op. cit; 20 nov., «Aniani ep. [Aurelianensis] et conf.». Pour plusieurs saints du calendrier on ne trouve pas d'office dans le sanctoral, et vice versa. — «Sequitur tabula impositionis historiarum...» (8-8v). F. 11-76 Psautier férial (11-72). — Office des défunts à l'usage d'Esztergom (72v-76); cf. K. Ottosen, The responsories and versicles of the latin office of the dead, Aarhus 1993, 127 (description des ff.74v-75v = «BN8879B») et 180 (description des ff.72v-74v = «BN8879A»). F. 77-528v Temporal : «Incipit breviarium secundum chorum alme ecclesie Strigoniensis. Dominica prima in adventu Domini...» (77-282v). Sanctoral : «Incipit secunda pars breviarii scilicet de festivitatibus. De s. Silvestro...» (286-486). À noter : office de l'Immaculée Conception composé par Léonard Nogarolo (480v). Commun des saints : «Incipit commune de sanctis et primo in vigilia unius apostoli...» (486v-513v). — «Sequitur de b. Virgine sabbatis diebus per estatem. Ad vesperas...» (513v-516v). «In quotidianis horis b. Virginis...» (516v-525). — «Sequuntur preces in quadragesima...» (525-526v). — «Sequuntur suffragia sabbatis diebus per estatem...» (526v-528), dont suffrages des ss. [Stephani regis Hungariae; Emerici ducis] (527), [Ladislai regis Hungariae; Adalberti ep. Pragensis et m.] (527v). — «Absolutio excommunicati...» (528-528v). 106 hymnes mentionnées dans la table des incipit, dont une non répertoriée dans Chevalier, Repert. hymn. ni dans les A. H., pour les confesseurs : «Christe lucis splendor vere fabrice mundi semper nobis parcens miserere confessorum precibus//...» (506v); cf. P. Radó, Répertoire hymnologique des mss. liturgiques dans les bibliothèques publiques de Hongrie, Budapest 1945, n° 111, relevée une fois dans le ms. Budapest, Bibl. nat. Hung. c. l. m. ae. 132, ms. décrit par Radó, Libri liturgici..., op. cit., 395-400.

[7 lettres d'Augusta Holmès à Jules Massenet, [entre 1892 et 1903]]

f.1-5, 7-8 : lettres, f.6 : carte ; f.1 daté d'après le contenu de la lettre, f.7-8 datés d'après l'année de décès d'Augusta Holmès